Viewing Study NCT07444918


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-31 @ 8:59 PM
Study NCT ID: NCT07444918
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-03
First Post: 2026-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module